Ocular Therapeutix Inc (STU:0OT)
€ 7.1 -0.20 (-2.74%) Market Cap: 1.55 Bil Enterprise Value: 1.04 Bil PE Ratio: 0 PB Ratio: 3.07 GF Score: 57/100

Ocular Therapeutix Inc SOL-1 Macula Society Presentation Review Transcript

Mar 02, 2026 / 12:30PM GMT
Release Date Price: €7.53 (+0.08%)

Mar 02, 2026 / 12:30PM GMT
Presentation Review
Mar 02, 2026 / 12:30PM GMT

=====================
Corporate Participants
=====================
* Bill Slattery Jr
Ocular Therapeutix Inc - Vice President, Investor Relations
* Pravin Dugel
Ocular Therapeutix Inc - Executive Chairman of the Board, President, Chief Executive Officer
* Jeffrey Heier
Ocular Therapeutix Inc - Chief Scientific Officer
* Peter Kaiser
Ocular Therapeutix Inc - Chief Development Officer

=====================
Conference Call Participants
=====================
* Tazeen Ahmad
Bank of America - Analyst
* Biren Amin
Piper Sandler - Analyst
* Colleen Kusy
Robert W. Baird & Co Inc - Analyst
* Sean McCutcheon
Raymond James - Analyst
* Lisa Walter
RBC Capital Markets Inc - Equity Analyst
* Clara Dong
Jefferies LLC - Equity Analyst
* Jon Wolleben
Citizens JMP - Analyst
* Yi Chen
H.C. Wainwright - Analyst
* Lachlan Hanbury-Brown
William

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot